PLT012 received FDA fast track status for liver cancer, with an ongoing trial evaluating safety and early activity of the CD36-targeting immunotherapy.

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer. Dr. Anjana Pillai explains, in an interview with ...

Scientists have identified a hidden barrier that prevents immunotherapy from working against a rare liver cancer. Immunotherapy, which activates the body’s own immune system to kill cancer cells, has ...

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

Researchers identified FABP4 as a driver of MASLD-related liver cancer. They developed a monoclonal antibody that neutralizes ...

Please provide your email address to receive an email when new articles are posted on . Alcohol is not the only cause of liver cancer; HBV, HCV and fatty liver disease are also risk factors. Awareness ...

In December, Detroit-based Barbara Ann Karmanos Cancer Center became the first facility in the world to offer at-home liver cancer treatment with the TheraBionic P1, a device recently approved by the ...

The liver is an extremely sensitive organ. It filters blood, eliminates toxins and creates bile to digest food; without a functioning liver, a person will die. Its sensitive nature, however, makes it ...

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...